Skip to content
Mainboard BSE,NSE Healthcare Upcoming

Sahajanand Medical Technologies IPO GMP Today

The Sahajanand Medical Technologies IPO GMP is ₹0 as of 10 Oct 2026, giving an estimated listing price of ₹0 per share.

Last updated

Issue Price
₹0
GMP
₹0
GMP %
—
Est. listing
₹0
Est. gain / application
—

Sahajanand Medical Technologies IPO GMP trend

Sahajanand Medical Technologies IPO GMP day-wise

No grey market activity has been reported for Sahajanand Medical Technologies IPO yet. GMP usually starts trading a few days before the issue opens.

Reading the Sahajanand Medical Technologies IPO GMP

The grey market premium is the price above the issue price at which Sahajanand Medical Technologies IPO shares are informally traded before listing. A GMP of ₹0 on an upper band of ₹0 suggests the shares could open around ₹0, if grey market sentiment holds until listing day.

GMP is not set by the company, the exchanges or SEBI. It moves daily with market conditions and subscription demand. Check it together with the subscription numbers and the company's financials before applying.

A zero GMP means grey market participants currently expect little or no premium on listing.

Sahajanand Medical Technologies IPO GMP: FAQs

What is Sahajanand Medical Technologies IPO GMP today?
The latest grey market premium (GMP) for the Sahajanand Medical Technologies IPO is ₹0 as of 10 October 2026.
What is the expected listing price of Sahajanand Medical Technologies IPO?
Based on the current GMP, the estimated listing price of Sahajanand Medical Technologies IPO is ₹0 per share (₹0 issue price + ₹0 GMP). This is an estimate from unofficial grey market trades, not a guaranteed listing price.
Is IPO GMP reliable?
GMP reflects unofficial trades before listing and changes daily with market mood and subscription demand. It is a useful sentiment indicator but often differs from the actual listing price, so use it alongside the company's financials and subscription data.

GMP is an unofficial indicator compiled from grey market sources and is not investment advice. Actual listing prices can differ significantly. Read the offer document before investing.